These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1693408)

  • 1. Preparation and characterization of neutralizing monoclonal antibodies to feline calicivirus.
    Tohya Y; Taniguchi Y; Tsubakimoto M; Takahashi E; Mikami T
    Nihon Juigaku Zasshi; 1990 Apr; 52(2):251-6. PubMed ID: 1693408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing epitopes of feline calicivirus.
    Tohya Y; Masuoka K; Takahashi E; Mikami T
    Arch Virol; 1991; 117(3-4):173-81. PubMed ID: 1708228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of amino acid substitutions escaping from a broadly neutralizing monoclonal antibody of feline calicivirus.
    Fujita S; Koba R; Tohya Y
    Virus Res; 2022 Sep; 318():198848. PubMed ID: 35691421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of conformational neutralizing epitopes on the capsid protein of canine calicivirus.
    Matsuura Y; Tohya Y; Mochizuki M; Takase K; Sugimura T
    J Gen Virol; 2001 Jul; 82(Pt 7):1695-1702. PubMed ID: 11413381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to feline calicivirus.
    Carter MJ; Routledge EG; Toms GL
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2197-200. PubMed ID: 2475582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a monoclonal antibody reacted broadly with feline calicivirus field isolates.
    Tajima T; Yoshizaki S; Nakata E; Tohya Y; Ishiguro S; Fujikawa Y; Sugii S
    J Vet Med Sci; 1998 Feb; 60(2):155-60. PubMed ID: 9524937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivities of feline calicivirus field isolates with monoclonal antibodies detected by enzyme-linked immunosorbent assay.
    Tajima T; Takeda Y; Tohya Y; Sugii S
    J Vet Med Sci; 1998 Jun; 60(6):753-5. PubMed ID: 9673951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of antigenic sites involved in neutralization on the capsid protein of feline calicivirus.
    Tohya Y; Yokoyama N; Maeda K; Kawaguchi Y; Mikami T
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():303-5. PubMed ID: 9018050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies.
    Cubillos-Zapata C; Angulo I; Almanza H; Borrego B; Zamora-Ceballos M; Castón JR; Mena I; Blanco E; Bárcena J
    Vet Res; 2020 May; 51(1):59. PubMed ID: 32357948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing determinants of canine herpesvirus as defined by monoclonal antibodies.
    Xuan X; Horimoto T; Limcumpao JA; Takumi A; Tohya Y; Takahashi E; Mikami T
    Arch Virol; 1991; 116(1-4):185-95. PubMed ID: 1705789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity.
    Afonso MM; Pinchbeck GL; Smith SL; Daly JM; Gaskell RM; Dawson S; Radford AD
    Vaccine; 2017 May; 35(20):2753-2760. PubMed ID: 28389099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
    Rong S; Lowery D; Floyd-Hawkins K; King V
    Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.
    Hohdatsu T; Sato K; Tajima T; Koyama H
    J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
    Huang C; Hess J; Gill M; Hustead D
    J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of human monoclonal antibodies that neutralize human rotavirus.
    Higo-Moriguchi K; Akahori Y; Iba Y; Kurosawa Y; Taniguchi K
    J Virol; 2004 Apr; 78(7):3325-32. PubMed ID: 15016854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates.
    Porter CJ; Radford AD; Gaskell RM; Ryvar R; Coyne KP; Pinchbeck GL; Dawson S
    J Feline Med Surg; 2008 Feb; 10(1):32-40. PubMed ID: 17720588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo.
    Poulet H; Jas D; Lemeter C; Coupier C; Brunet S
    Vaccine; 2008 Jul; 26(29-30):3647-54. PubMed ID: 18541348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic change in feline calicivirus during persistent infection.
    Johnson RP
    Can J Vet Res; 1992 Oct; 56(4):326-30. PubMed ID: 1335833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the subunit particles of feline calicivirus.
    Tohya Y; Tsubakimoto M; Horimoto T; Takahashi E; Mikami T
    Nihon Juigaku Zasshi; 1990 Oct; 52(5):955-61. PubMed ID: 2280505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.